BBLG

Bone Biologics Corporation
0.30
0.0148 (5.19%)

Bone Biologics Corp (BBLG) Fundamentals

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
SHARE INFORMATION
Market Cap$ 4,364,126
Shares Outstanding15,301,986
Float8,096,736
Percent Float52.91%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.35
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions9
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,712
Institutional Holdings Percent0.5%
Institutional Sold Previous 3 Months-
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent27.0
Insider Sold Previous 3 Months-
Insider Shares Owned4,125,117
TRADING INFO
52 Week High$ 4.07
52 Week Low$ 0.18
52 Week High Change$ -86.42
21 Day Moving Average$ 0.2919
21 Day Extended Moving Average$ 0.289935
50 Day Moving Average$ 0.2675
50 Day Extended Moving Average$ 0.326292
200 Day Moving Average$ 0.994504
200 Day Extended Moving Average$ 1.0769
10 Day Average Volume329,424
20 Day Average Volume257,474
30 Day Average Volume278,333
50 Day Average Volume308,142
Alpha0.077357
Beta4.5324
Standard Deviation0.868659
R20.112361
7 Day Price Change$ -0.0313
7 Day Percent Change-9.89%
21 Day Price Change$ -0.0148
21 Day Percent Change-4.93%
30 Day Price Change$ 0.0755
30 Day Percent Change36.0%
Month to Date Price Change$ 0.0026
Month to Date Percent Change0.92%
Quarter to Date Price Change$ 0.0755
Quarter to Date Percent Change36.0%
180 Day Price Change$ -0.9984
180 Day Percent Change-77.78%
200 Day Price Change$ -0.9032
200 Day Percent Change-76.0%
Year to Date Price Change$ 0.0755
Year to Date Percent Change36.0%

Bone Biologics Corp (BBLG) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.00
Total Debt To Equity0.00
Int Coverage-172.00
Current Ratio6.50
Leverage Ratio1.10
Quick Ratio6.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.00
Enterprise Value$ 17,278,607
Price to Sales0.00
Price to Free Cash-2.80
PE High Last 5 Years-10.30
Price To Book1.00
Price To Cash Flow0.00
PE Low Last 5 Years-5.30
Price to Tangible Book1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-97.30
Return on Equity47.67
Return on Capital-43.46

Bone Biologics Corp (BBLG) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWeinberg & Company, P.A.
CEOJeffrey Frelick
Emplyoees2
Last AuditUE
CIK0001419554
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2 Burlington Woods Drive
Suite 100
Burlington, MA 1803
Websitehttps://www.bonebiologics.com
Facsimile-
Telephone+1 781 552-4452
Email-


Your Recent History
NASDAQ
BBLG
Bone Biolo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.